LLY vs PG: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Eli Lilly and Company · Healthcare
$1,183.72
+2.1% upside to fair value
Med Conviction
Grade B
High Quality
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
PG has more upside to fair value
(+14.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
PG |
| Current Price |
$1,183.72 |
$147.04 |
| Fair Value Estimate |
$1,208.00 |
$168.19 |
| Upside to Fair Value |
+2.1%
|
+14.4%
|
| Market Cap |
$1,114.8B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
26.8x
|
17.6x
|
| Price / Sales |
14.0x
|
4.0x
|
| Price / FCF |
52.7x
|
22.4x
|
| Revenue Growth YoY |
+47.7%
|
+1.5%
|
| Gross Margin |
83.4%
|
50.2%
|
| Operating Margin |
49.7%
|
22.7%
|
| Return on Equity |
92.6%
|
29.8%
|
| Dividend Yield |
0.57% |
2.92% |
| FCF Yield |
1.9%
|
4.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Eli Lilly is a global pharmaceutical company whose incretin franchise, led by Mounjaro and Zepbound, has become the dominant growth engine in diabetes and obesity care. The business quality is high: TTM gross margin is 83.4%, TTM operating margin is 49.7%, TTM net margin is 33.5%, and ROE is 92.6%, while revenue grew 47.7% and earnings grew 25.3% in the most recent quarter on a year-over-year bas…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
LLY |
PG |
| Zone Low |
$906.00 |
$126.14 |
| Zone High |
$1,026.80 |
$142.96 |
| In Buy Zone? |
No
|
No
|